Asian stocks saw its biggest sell off in eight sessions on Thursday as the rise in COVID-19 cases and the lowering of economic forecasts by the International Monetary Fund dented confidence in a recovery. However, bonds saw some gains, while the U.S. Dollar held steady.
MSCI’s broadest index of Asia-Pacific shares lost 0.7%, while Japan’s Nikkei slipped by 1.1%.
Down Under, the ASX 200 lost 2.1%.
U.S. stock futures dipped by 0.4%, signaling that Wall Street’s slide on Wednesday may need more for recovery.
European stock futures, despite strong data, last traded slightly in the red.
Germany’s DAX fell by 0.1%, while EuroSTOXX futures dipped by 0.3%.
Meanwhile, Britain’s FTSE futures lost 0.4%.
American states including Florida, Oklahoma, and South Carolina reported a record surge in new COVID-19 cases on Wednesday, while Australia reported its biggest daily rise in infections in two months.
Market sentiment further soured when the International Monetary Fund changed its projections from a 3% contraction in global GDP to a 4.9% in 2020.
Meanwhile, the U.S. Dollar held its ground to broad gains overnight, recovering from a near 2-week low.
Oil traded higher on Friday, further reclaiming lost ground from three-week lows in the previous session as the COVID-19 situation continued to dent the global economy as well as oil consumption. Brent crude gained 0.3%, trading at $43.08 ...
Asian shares recorded a turbulent session on Friday as weak economic data from the United States and surging coronavirus infections worldwide dragged market confidence. The decline followed despite upbeat U.S. tech gains and signs of rebound ...
Asian stocks advanced on the prospect of ultra-easy monetary policy as the U.S. Federal Reserve kept interest rates near zero. Fed deemed it necessary to salvage the ailing economy, dragging the dollar down to a two-year low. The target range ...
On Wednesday, European stocks rose slightly after mixed earnings reports. However, the new wave of the coronavirus outbreak kept investors cautious while they also wait for the U.S. Federal Reserve’s announcement. The Stoxx Europe 600 ...
Britain on Wednesday signed a supply deal for up to 60 million doses of a possible COVID-19 vaccine that is being developed by pharmaceutical companies GlaxoSmithKline (GSK) and Sanofi. The financial details of the agreement were not disclosed. However, ...